1. The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response
   Gabriella Pagnan et al, 2009, Clinical Cancer Research CrossRef
2. Bortezomib Is Toxic but Induces Neurogenesis and Inhibits TUBB3 Degradation in Rat Neural Stem Cells
   Seung Yeon Sohn et al, 2024, Biomolecules & Therapeutics CrossRef
3. Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN
   Maria E. Rich et al, 2017, Journal of Cancer Therapy CrossRef